Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
We’ve made a few mistakes in the past two years, when it comes to developing COVID drugs. Some were obvious and could have easily been avoided.
South Africa has a stringent pharmaceutical regulatory framework. But this framework is not backed by a strong implementation strategy.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
A new study suggests the market alone will not deter or punish pharmaceutical companies whose products turn out to have adverse effects after they have been approved.
Non-intoxicating cannabis products are safe and well tolerated by those who use them, so why not lower the clinical threshold for their manufacture and sale?
The path to using old drugs for COVID is full of potholes. So why are we using the same old flawed methods when we actually know what works?
Here’s how to make the learning process fun and safe.
Chemicals in drugs can be excreted unchanged, infiltrating waterways via sewage and effluent.
The pharmaceutical industry overall has been deeply opposed to waiving COVID-19 vaccine patents, but a historian of the industry explains that drug companies once opposed patents altogether.
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
The Nigerian government must shore up efforts to stop the pollution of aquatic environments.
COVID has now claimed over 200,000 lives on the subcontinent, and the knock-on effects are likely to be substantial.
The FDA recalled commonly used heartburn and ulcer medication ranitidine in April 2020. But new research suggests less reason for alarm.
COVID-19 has resulted in higher than normal levels of medicine shortages. Here’s what to do if your local pharmacy is out of stock.
The world leader in generic medicines is facing stiff competition.
Details are sketchy. But it looks like people would still need to go through the legal system to get compensation. There are better ways.
Medical innovation is often accelerated in a time of crisis.
Health Canada devotes far more resources to getting new drugs onto the market compared to making sure that drugs already being sold are safe.
Word that the U.S. has bought up the entire supply of the COVID-19 drug remdesivir is another reminder that in a pandemic, treatments and vaccines need to be accessible to everyone, globally.